ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma
RNA-seq (gene expression) · human · 50 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 50 samples: 41 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE275637_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1152348 and SRA study SRP528057. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 50 sample titles: 41 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8477141 i10-control-24hr_S10
- GSM8477142 i11-control-24hr_S11
- GSM8477143 i12-control-24hr_S12
- GSM8477144 i13-control-72hr_S13
- GSM8477145 i14-control-72hr_S14
- GSM8477146 i15-control-72hr_S15
- GSM8477147 i16-control-72hr_S16
- GSM8477148 i17-1392-6hr_S17
- GSM8477149 i18-1392-6hr_S18
- GSM8477150 i19-1392-6hr_S19
- GSM8477151 i1-control-0hr_S1
- GSM8477152 i20-1392-6hr_S20
- GSM8477153 i21-1392-24hr_S21
- GSM8477154 i22-1392-24hr_S22
- GSM8477155 i23-1392-24hr_S23
- GSM8477156 i24-1392-24hr_S24
- GSM8477157 i25-1392-72hr_S25
- GSM8477158 i26-1392-72hr_S26
- GSM8477159 i27-1392-72hr_S27
- GSM8477160 i28-1392-72hr_S28
- GSM8477161 i29-1805-6hr_S29
- GSM8477162 i2-control-0hr_S2
- GSM8477163 i30-1805-6hr_S30
- GSM8477164 i31-1805-6hr_S31
- GSM8477165 i32-1805-6hr_S32
- GSM8477166 i33-1805-24hr_S33
- GSM8477167 i34-1805-24hr_S34
- GSM8477168 i35-1805-24hr_S35
- GSM8477169 i36-1805-24hr_S36
- GSM8477170 i37-1805-72hr_S37
- GSM8477171 i38-1805-72hr_S38
- GSM8477172 i39-1805-72hr_S39
- GSM8477173 i3-control-0hr_S3
- GSM8477174 i40-1805-72hr_S40
- GSM8477175 i4-control-0hr_S4
- GSM8477176 i5-control-6hr_S5
- GSM8477177 i6-control-6hr_S6
- GSM8477178 i7-control-6hr_S7
- GSM8477179 i8-control-6hr_S8
- GSM8477180 i9-control-24hr_S9
+ 10 more — browse all 50 samples with per-sample file links →
- GSE292538 KRAS-Dependent Metabolic Reprogramming of Endothelial Cells as a Therapeutic Vulnerability in Brain Arteriovenous Malformations 18 samples shares vulnerability, therapeutic
- GSE295392 PIKfyve-regulated lipid metabolism as a therapeutic vulnerability in neuroendocrine prostate cancer 82 samples shares vulnerability, therapeutic
- GSE280973 Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma 20 samples shares vulnerability, therapeutic
- GSE269369 LIN28B-mediated activation of the PI3K/AKT pathway promotes metastasis and unravels a new therapeutic vulnerability in colorectal cancer 18 samples shares vulnerability, therapeutic
- GSE293843 Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors [RNA-Seq] 10 samples shares vulnerability, therapeutic
- GSE269629 Metabolic programs drive function of therapeutic natural killer (NK) cells in low oxygen tumor microenvironments 63 samples shares therapeutic
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples shares therapeutic
- GSE252799 Zongertinib (BI01810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers 90 samples shares therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.